Search results - 4 results
Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
Verburgh; Marjorie Meurisse; Steven Van Gucht; Veronik Hutse Source: BMC Public Health, Volume 19, Issue 1 (2019) Abstract: BACKGROUND: Prevalence data of chronic hepatitis C virus (HCV) infection are needed ...
Distribution of HCV genotypes in Belgium from 2008 to 2015.
RESULTS: For the study period, 11,033 unique records collected by the participating laboratories were used for further investigation. HCV genotype 1 was the most prevalent (53.6%) genotype in Belgium, with ...
Hepatitis E virus serology and PCR: does the methodology matter?
quality control (EQC) samples. In a period of 39 months (January 2011-April 2014), 70 patients were enrolled. Using different ELISA assays, the prevalence of antibodies varied from 5.7% to 14.3% for HEV IgM ...
Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study.
Keywords: Belgium cross-sectional studies Hepacivirus Hepatitis C Humans Mass Screening Substance Abuse, Intravenous Abstract: BACKGROUND: Hepatitis C prevalence figures for people who use drugs in Belgium ...